Epstein-Barr Antigen IgM IgA Antibody Detection Kit Hongmian CE Certified Supplier

EBV Detection Kit Features:

Full-cycle assessment: Simultaneous detection of key EBV infection antibodies IgM (a marker of recent/acute infection) and IgA (a warning of recovery/potential risk), covering the entire stage from acute infection to past infection to risk monitoring, assisting clinicians in accurately assessing infection status and associated disease risks.

Preparation-free samples: Supports direct whole blood testing, eliminating complex pretreatment steps, reducing equipment dependence, shortening test preparation time, and adapting to rapid screening needs in emergency departments, primary care settings, and other scenarios.

International certification: Certified by the European Union (compliant with IVDR standards), rigorously validating sensitivity, specificity, and safety to ensure stable and reliable test results, meeting the requirements for clinical compliance in multiple regions worldwide.

Rapid identification: For diseases caused by EBV such as infectious mononucleosis and nasopharyngeal carcinoma, dynamic antibody changes help rapidly identify the infection stage (acute/past), providing crucial evidence for symptom attribution (e.g., fever, sore throat) and tumor risk monitoring, optimizing clinical decision-making efficiency.

Multi-terminal adaptation: Compatible with hospital laboratories, community centers, third-party laboratories and other scenarios, supporting diverse needs such as outpatient screening and inpatient tracking, and flexibly responding to different levels of pathological analysis tasks.